Franklin Resources Boosts Stake in Regeneron Pharmaceuticals

Investment firm increases holdings in biotech company by 6% in Q3

Mar. 11, 2026 at 10:50am

Got story updates? Submit your updates here. ›

Franklin Resources Inc. has increased its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) by 6.0% during the third quarter, according to a recent SEC filing. The investment firm now owns 2,453,143 shares of the biopharmaceutical company's stock, representing 2.33% ownership.

Why it matters

Regeneron is a leading biotech company known for its innovative drug discovery technologies and pipeline of biologic therapies. Franklin Resources' increased investment signals confidence in the company's long-term growth potential.

The details

According to the SEC filing, Franklin Resources purchased an additional 139,647 shares of Regeneron during the third quarter, bringing its total holdings to 2,453,143 shares. This represents a 6.0% increase in the firm's stake in the biopharmaceutical company.

  • The transactions occurred during the third quarter of 2026.

The players

Franklin Resources Inc.

A global investment management organization with over $1.5 trillion in assets under management.

Regeneron Pharmaceuticals, Inc.

A U.S. biotechnology company focused on discovering, developing, manufacturing, and commercializing medicines for serious medical conditions.

Got photos? Submit your photos here. ›

The takeaway

Franklin Resources' increased investment in Regeneron Pharmaceuticals underscores the biotech firm's strong market position and growth potential in the pharmaceutical industry.